Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Stock (NASDAQ: SNGX) stock price, news, charts, stock research, profile.
Day Range0.437 - 0.480 | 52 Wk Range0.380 - 1.000 | Open / Close0.480 / - | Float / Outstanding43.176M / 43.335M |
Vol / Avg.185.549K / 90.321K | Mkt Cap19.579M | P/E- | 50d Avg. Price0.540 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float43.176M | EPS-0.340 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-28 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 200.000K | 200.000K | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soligenix (NASDAQ: SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Humanigen (NASDAQ:HGEN), Geovax Labs (NASDAQ:GOVX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Soligenix (NASDAQ: SNGX) was reported by B. Riley Securities on Friday, December 4, 2020. The analyst firm set a price target for 4.00 expecting SNGX to rise to within 12 months (a possible 785.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soligenix (NASDAQ: SNGX) is $0.4518 last updated Today at January 31, 2023 at 5:46 PM UTC.
There are no upcoming dividends for Soligenix.
Soligenix’s Q4 earnings are confirmed for Tuesday, March 28, 2023.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.